Evaluation of cytologic specimens obtained during experimental vitreous biopsy using B-cell lymphoma line.

Tingting Jiang, Zhenyang Zhao, Qing Chang

Journal: European journal of ophthalmology 2014;24(6):911-7

PMID: 24846625

Abstract

PURPOSE

To investigate the role of vitrectomy in the diagnosis of intraocular lymphoma by evaluating the effects of aspiration pressure and cut rate on cell viability and diagnostic yield.

METHODS

Cells of the human Burkitt lymphoma cell line Namalwa were processed by 20-G vitrectomy under 2 different aspiration pressures and at different cut rates. Some samples were divided into high and low aspiration pressure groups and were then divided into 6 subtypes according to the different cut rates (0, 300, 600, 800, 1500, or 2500 cuts per minute [cpm]). Other samples were treated with dexamethasone sodium phosphate for 48 hours with or without further culturing in cell culture media afterward. The cell viability in each subtype group was determined using trypan blue staining and the Cell Counting Kit-8.

RESULTS

The number of viable cells was reduced with increasing cut speed under high aspiration pressure. Cell viability began to decrease at 600 cpm and was lowest at 2500 cpm. Exposure to dexamethasone sodium phosphate induced destruction of cellular structure and a significant reduction in cell viability. However, cell viability could be recovered with further culture in cell culture media for 1 week.

CONCLUSIONS

A cut rate of 600 cpm or less is recommended during diagnostic vitrectomy to confirm a clinical suspicion of primary intraocular lymphoma. Corticosteroid treatment can lower the diagnostic yield due to reduced cell viability and damaged cellular structure.

Address: Department of Ophthalmology, Eye and ENT Hospital, Fudan University, Shanghai - China.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.